-
ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma
ImmunoCellular Therapeutics, Ltd (OTCBB: IMUC) today announced it will be presenting new data from the Phase I clinical trial of ICT107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme ... mehr